NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 9,395,986
- Share change
- +401,483
- Total reported value
- $22,737,366
- Put/Call ratio
- 0%
- Price per share
- $2.42
- Number of holders
- 32
- Value change
- +$2,030,864
- Number of buys
- 14
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.3%
|
5,980,568
|
$4,927,390 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.31%
|
822,041
|
$677,000 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.18%
|
483,647
|
$398,477 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.14%
|
363,200
|
$299,240 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
318,546
|
$262,482 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
210,366
|
$173,321 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.06%
|
162,580
|
$133,950 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.05%
|
120,909
|
$99,617 | — | 31 Mar 2025 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.03%
|
74,723
|
$61,564 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
63,800
|
$52,565 | — | 31 Mar 2025 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.02%
|
63,730
|
$52,507 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
61,478
|
$50,652 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
58,358
|
$48,081 | — | 31 Mar 2025 | |
| HBK Sorce Advisory LLC |
13F
|
Company |
0.02%
|
46,060
|
$37,949 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
34,817
|
$28,686 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
30,370
|
$25,022 | — | 31 Mar 2025 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
28,760
|
$23,695 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
22,037
|
$18,156 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
15,991
|
$13,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0%
|
10,685
|
$8,803 | — | 31 Mar 2025 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0%
|
10,000
|
$8,239 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
5,000
|
$4,120 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
3,229
|
$2,000 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
905
|
$746 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
566
|
$466 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
361
|
$297 | — | 31 Mar 2025 | |
| Vermillion Wealth Management, Inc. |
13F
|
Company |
0%
|
200
|
$165 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
50
|
$41 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
30
|
$24 | — | 31 Mar 2025 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2025
As of 30 Jun 2025,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,395,986 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., Candriam S.C.A., SG Americas Securities, LLC, TWO SIGMA ADVISERS, LP, UBS Group AG, Aberdeen Group plc, BNP PARIBAS FINANCIAL MARKETS, TWO SIGMA INVESTMENTS, LP, Ariose Capital Management Ltd, and Alberta Investment Management Corp.
This page lists
32
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
29
Q2 2025 holders
32
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.